The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

Kennedy Jr., the Trump administration has begun restricting access to COVID vaccines as well as credible vaccine guidance. On ...

The U.S. is up to 1,168 confirmed measles cases this year. Texas added four cases in the last week, which shows continued ...

A federal judge in California has blocked the Trump administration from enforcing anti-diversity and anti-transgender ...

Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

The Advisory Committee on Immunization Practices helps the agency make recommendations on who should get certain vaccines.

As summer temperatures climb and families head outdoors, health officials are urging Kansans to take steps to protect ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

HHS Secretary Robert F. Kennedy on Monday removed all 17 members of the expert panel that makes vaccine policy ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's ...

The average woman's weight can vary depending on age, physical traits, certain health conditions, metabolism, appetite, and ...

While Lyme disease gets the most attention – and affects the most people – there are other tick-borne bacteria and diseases ...